| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
2017-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2019-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2019521142-A |
| titleOfInvention |
Novel tetrahydropyrazolopyridine compounds for the treatment of infectious diseases |
| abstract |
The present invention relates to a compound of formula (I) wherein R 1 to R 5 are as described above, or a pharmaceutically acceptable salt, enantiomer or diastereomer thereof. The compounds may be useful for the treatment or prevention of hepatitis B virus infection. |
| priorityDate |
2016-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |